Incyte Historical Cash Flow
| INCY Stock | USD 53.43 0.42 0.78% |
Analysis of Incyte cash flow over time is an excellent tool to project Incyte future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Begin Period Cash Flow of 3.1 B or Depreciation of 86.8 M as it is a great indicator of Incyte ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Incyte latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Incyte is a good buy for the upcoming year.
Incyte |
About Incyte Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Incyte balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Incyte's non-liquid assets can be easily converted into cash.
Incyte Cash Flow Chart
Incyte Cash Flow Statement became part of mandatory reporting in 1987. It is now one of three main statements in accounting used to measure how well a company manages its liquidity and overall cash position. The rate of cash utilization and preservation is now part of the leading indicators of a healthy entity, and the Incyte Cash Flow Statement shows how well the company generates cash to payout debt obligations or to cover ongoing operating expenses.
At this time, Incyte's Change To Netincome is fairly stable compared to the past year. Change To Liabilities is likely to rise to about 393.2 M in 2024, despite the fact that Change In Working Capital is likely to grow to (236.2 M). Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by Incyte to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Incyte operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Incyte's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Incyte current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Incyte. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide.At this time, Incyte's Change To Netincome is fairly stable compared to the past year. Change To Liabilities is likely to rise to about 393.2 M in 2024, despite the fact that Change In Working Capital is likely to grow to (236.2 M).
Incyte cash flow statement Correlations
Click cells to compare fundamentals
Incyte Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Incyte cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 668.7M | (318.9M) | 544.4M | 894.0M | 262.1M | 275.2M | |
| Free Cash Flow | 632.6M | (312.0M) | 568.5M | 892.1M | 449.0M | 471.5M | |
| Change In Working Capital | 57.3M | (71.7M) | (14.6M) | 198.8M | (248.7M) | (236.2M) | |
| Begin Period Cash Flow | 1.2B | 1.8B | 1.5B | 2.1B | 3.0B | 3.1B | |
| Other Cashflows From Financing Activities | 16.7M | 7.8M | 9.8M | (6.4M) | (52.5M) | (49.9M) | |
| Depreciation | 54.5M | 51.8M | 57.8M | 67.9M | 82.7M | 86.8M | |
| Other Non Cash Items | (14.3M) | 13.5M | 40.2M | 117.1M | 7.9M | 7.5M | |
| Capital Expenditures | 78.1M | 187.4M | 181.0M | 77.8M | 47.5M | 42.9M | |
| Total Cash From Operating Activities | 710.7M | (124.6M) | 749.5M | 969.9M | 496.5M | 521.3M | |
| Net Income | 446.9M | (295.7M) | 948.6M | 340.7M | 597.6M | 627.5M | |
| Total Cash From Financing Activities | 45.7M | 71.7M | 6.2M | (794K) | (20.0M) | (19.0M) | |
| End Period Cash Flow | 1.8B | 1.5B | 2.1B | 3.0B | 3.2B | 3.4B | |
| Sale Purchase Of Stock | (16.8M) | (22.8M) | (29.9M) | (26.3M) | (30.2M) | (28.7M) | |
| Change To Inventory | (6.1M) | (19.5M) | (21.0M) | (67.5M) | (170.2M) | (178.7M) | |
| Stock Based Compensation | 166.6M | 177.9M | 183.0M | 188.4M | 215.9M | 226.7M | |
| Total Cashflows From Investing Activities | (87.5M) | (269.0M) | (207.7M) | (78.5M) | (70.7M) | (74.2M) | |
| Change To Account Receivables | (1.2M) | (173.2M) | (134.3M) | (28.6M) | (98.7M) | (93.7M) | |
| Investments | (9.4M) | (81.6M) | (26.7M) | (709K) | (74.1M) | (77.8M) | |
| Change Receivables | (1.2M) | (173.2M) | (134.3M) | (28.6M) | (25.7M) | (27.0M) | |
| Cash And Cash Equivalents Changes | 668.9M | (321.9M) | 548.0M | 890.6M | 1.0B | 1.1B | |
| Cash Flows Other Operating | (28.7M) | (18.5M) | (40.0M) | 56.9M | 65.4M | 68.6M | |
| Change To Netincome | 186.4M | 201.5M | (266.4M) | 275.0M | 316.3M | 332.1M | |
| Change To Liabilities | 58.9M | 129.0M | 204.8M | 325.6M | 374.5M | 393.2M | |
| Change To Operating Activities | 84.8M | 105.8M | 67.4M | 189.5M | 217.9M | 228.8M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Incyte. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide.Note that the Incyte information on this page should be used as a complementary analysis to other Incyte's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Complementary Tools for Incyte Stock analysis
When running Incyte's price analysis, check to measure Incyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Incyte is operating at the current time. Most of Incyte's value examination focuses on studying past and present price action to predict the probability of Incyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Incyte's price. Additionally, you may evaluate how the addition of Incyte to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |
Is Incyte's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incyte. If investors know Incyte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Incyte listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 6.324 | Earnings Share 2.65 | Revenue Per Share 16.526 | Quarterly Revenue Growth 0.093 | Return On Assets 0.0646 |
The market value of Incyte is measured differently than its book value, which is the value of Incyte that is recorded on the company's balance sheet. Investors also form their own opinion of Incyte's value that differs from its market value or its book value, called intrinsic value, which is Incyte's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incyte's market value can be influenced by many factors that don't directly affect Incyte's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Incyte's value and its price as these two are different measures arrived at by different means. Investors typically determine if Incyte is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Incyte's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.